Jazz Pharmaceuticals (JAZZ) PT Raised to $166 at SunTrust
Tweet
Share
E-mail
Get Alerts JAZZ Hot Sheet
Price: $107.43 -0.82%
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
SunTrust raised its price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $166.00 (from $163.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teradyne (TER) PT Raised to $125 at TD Cowen
- Parade Technologies Ltd. (4966:TT) PT Lowered to NT$870 at Nomura/Instinet
- Zhongji Innolight Co Ltd (300308:CH) PT Raised to RMB223.80 at HSBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
